Teradyne price target lowered at Cantor Fitzgerald, selloff ‘not a surprise’

Cantor Fitzgerald analyst C.J. Muse lowered the firm’s price target on Teradyne (TER) to $150 from $160 and keeps an Overweight rating on the shares. Teradyne reported another disappointing quarter, and while much of the commentary was largely as expected, the guidance for both Q1 and calendar 2025 was below consensus, the analyst tells investors in a research note. The firm says the selloff is “not a surprise,” and that the messaging on the call was “muddled,” including restructuring of the Robotics business, Q1 guidance, soft Q2 guidance, and “very little” information on 2026, a major focus for investors. Cantor thinks it might take time for shares to push higher.